Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D005260:Female; D006084:Graft Rejection / Q000187:drug effects*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012086:Reoperation; D013601:T-Lymphocytes / Q000276:immunology*
D000961:Antilymphocyte Serum